Login / Signup

CURATE.AI-assisted dose titration for anti-hypertensive personalized therapy: study protocol for a multi-arm, randomized, pilot feasibility trial using CURATE.AI (CURATE.AI ADAPT trial).

Anh T L TruongShi-Bei TanGolda Z WangAlexander W J YipMathias EgermarkWesley YeungV Vien LeeMark Y ChanKirthika Senthil KumarLester Wen Jeit TanSmrithi VijayakumarAgata BlasiakLaureen Yi-Ting WangDean Ho
Published in: European heart journal. Digital health (2023)
NCT05376683.
Keyphrases
  • phase iii
  • artificial intelligence
  • phase ii
  • study protocol
  • open label
  • clinical trial
  • double blind
  • placebo controlled
  • blood pressure
  • randomized controlled trial
  • machine learning
  • cell therapy